This course expires August 1st, 2018
If you want credit, this course must be completed (i.e. view the recording, pass the posttest, AND print the certificate) by no later than July 31st, 2018
Please note, after this course has expired, no aspect of the course will be accessible, including the recorded lecture.
A certified, one-hour prerecorded webinar for radiologists and other healthcare professionals who treat and manage patients with breast disease.
With FDA approval of DBT, the medical community is faced with evaluating DBT in terms of providing improved care for their patient population and the impact of this new technology on their medical practice. This evaluation process involves consideration of the pros and cons of the technology compared to their current practice, patient selection criteria, and operational concerns.
Faculty will begin the session with an overview of DBT technology and then provide an intensive review of malignant, benign, and dense breast cases.
Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and the International Center for Postgraduate Medical Education.The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
SA-CME: This activity meets the criteria for self-assessment toward the purpose of fulfilling requirements in the American Board of Radiology (ABR) Maintenance of Certification Program.
The European Accreditation Council for CME (EACCME®)
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live events and e-learning materials. For more information go to https://www.ama-assn.org/education/uemseaccme-cme-credit-recognition .
Radiologic Technologists
This program has been approved by the American Society of Radiologic Technologists (ASRT) for 1.0 hour of ARRT Category A continuing education credit.
Linda R.N. Greer, MD
Medical Director
John C. Lincoln Breast Health and Research Center
Phoenix, AZ
Dr. Greer received her medical degree from University of Texas Medical Branch, Galveston, where she also completed her residency in diagnostic radiology.
Dr. Greer currently serves as medical director of the John C. Lincoln Breast Health and Research Center in Phoenix, AZ. In 2012, she was named Physician of the Year, representing Deer Valley Hospital, part of the John C. Lincoln Health Network.
Dr. Greer’s research and educational interests are on gene testing of malignancies, synthetic view reading, and DBT implementation and interpretation. She recently published an article on tomosynthesis in Applied Radiology.
Conflict of Interest
The Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty below have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Linda R.N. Greer, MD
The planners and managers below reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Laura Excell, MD
Trace Hutchison, PharmD
Samantha Mattiucci, PharmD
Linda McLean, MS
Victoria Phoenix, BS
Lisa Schleelein, MEd
Patricia Staples, MSN, NP-C, CCRN
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. PIM, ICPME and Hologic do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ICPME, and Hologic. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Questions
For questions regarding this program, please contact ICPME:
Email: information@icpmed.com
Phone: 607-257-5860 x10
JOINTLY PROVIDED BY
THIS ACTIVITY IS SUPPORTED BY AN INDEPENDENT EDUCATIONAL GRANT FROM HOLOGIC, INC.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.